A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: Methylphenidate;   Drug: Lisdexamfetamine;   Drug: Atomoxetine;   Drug: Amphetamine;   Drug: Dextroamphetamine Sponsor:   Janssen Research & Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC) Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Exercise Intervention on Inhibition in Children With Attention-deficit Hyperactivity Disorder
Condition:   Exercise Intervention Intervention:   Other: High-intensity interval training Sponsor:   National Taiwan Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition:   Attention Deficit Hyperactivity Disorder Interventions:   Behavioral: Mobile Neurofeedback;   Other: Treatment as Usual Sponsors:   Sheba Medical Center;   Myndlift Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation
Condition:   ADHD Predominantly Inattentive Type Interventions:   Behavioral: Cognitive-behavioral therapy (Hesslinger protocol);   Behavioral: Cognitive-behavioral therapy (CADDI protocol) Sponsor:   Karolinska Institutet Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2019 Category: Research Source Type: clinical trials